NIH Grants $470 Million for Study of Long COVID
NIH Grants $470 Million for Study of Long COVID
Lisa Winter | Sep 16, 2021
The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.
A Surge in Pandemic Research Shines a Spotlight on Preprints
A Surge in Pandemic Research Shines a Spotlight on Preprints
Diana Kwon | Sep 10, 2021
Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.
Opinion: An Alternative to Injection
Opinion: An Alternative to Injection
Carmine D’Amico, Hélder Santos | Sep 9, 2021
Research on microneedle patches for vaccine delivery has grown in popularity in recent years, due to their exceptional compliance and low invasiveness.
How Wildfire Smoke Raises Infectious Disease Risk
How Wildfire Smoke Raises Infectious Disease Risk
Amanda Heidt | Sep 8, 2021
As fires blanket growing swathes of the West, scientists are beginning to understand more about how their smoke affects the transmission and severity of COVID-19 and other illnesses, and how it differs from that of other types of air pollution.
Q&A: Health of 9/11 First Responders 20 Years Later
Q&A: Health of 9/11 First Responders 20 Years Later
Amanda Heidt | Sep 7, 2021
The Scientist spoke with Rachel Zeig-Owens, the director of epidemiology for the World Trade Center Health Program, about what scientists have learned after two decades of studying illness and disease among survivors.
What We Know About Mu, the WHO’s Latest Variant of Interest
What We Know About Mu, the WHO’s Latest Variant of Interest
Christie Wilcox | Sep 7, 2021
The SARS-CoV-2 variant was first detected in January, but its rising prevalence and potential resistance to vaccines has garnered it special attention from the World Health Organization.
“Mystery Fever” Claims the Lives of Dozens of Indian Children
“Mystery Fever” Claims the Lives of Dozens of Indian Children
Lisa Winter | Sep 2, 2021
So far, more than 50 people have died of a febrile illness, though the cause isn’t clear.
The Long Journey to Resolve the Origins of a Previous Pandemic
The Long Journey to Resolve the Origins of a Previous Pandemic
Martha Nelson | Sep 2, 2021
Dozens of researchers, including myself, worked for years to uncover that swine flu had leapt to humans from a pig in Mexico in 2009. We learned a lot about influenza evolution, pig farming, and outbreak risk along the way.
New Chernobyl Initiative Aims to Boost Research on the Area
New Chernobyl Initiative Aims to Boost Research on the Area
Stefan Weichert | Sep 1, 2021
Sergii Mirnyi, one of the people who helped clean up after the 1986 disaster, says he founded Chornobyl University to promote much-needed interdisciplinary research on the Chernobyl Exclusion Zone.
Opinion: What the History of Blood Transfusion Reveals About Risk
Opinion: What the History of Blood Transfusion Reveals About Risk
Paul A. Offit | Sep 1, 2021
Every medical intervention—even one with a centuries-long history—brings dangers, some of which become clear only later.
Delta Blues
Delta Blues
Bob Grant | Sep 1, 2021
Humanity was hoping to emerge from the COVID-19 pandemic this year. But viruses have plenty of tools at their disposal, and we should plan for a long-term future in which SARS-CoV-2 is a persistent threat.
Opinion: The Pandemic and the RNA Sequencing Gap
Opinion: The Pandemic and the RNA Sequencing Gap
Robert Ross | Sep 1, 2021
RNA sequencing technology lags far behind researchers’ ability to decode and understand DNA. The COVID-19 pandemic has highlighted this dangerous shortcoming.
Study Reveals Declining COVID-19 Vaccine Efficacy Against Infection
Study Reveals Declining COVID-19 Vaccine Efficacy Against Infection
Annie Melchor | Aug 25, 2021
The vaccines remain protective against serious disease and death.
FDA Approves Pfizer-BioNTech COVID-19 Vaccine
FDA Approves Pfizer-BioNTech COVID-19 Vaccine
Annie Melchor | Aug 23, 2021
The milestone marks the first fully-approved COVID-19 vaccine in the United States.